Trials / Unknown
UnknownNCT02516371
Lymphocytes Subpopulation in Cancer Patients
Lymphocytes Subpopulation and Its Relevance With Tumor Grade and Prognosis in Cancer Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- DERSHENG SUN · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.
Detailed description
The host's inflammatory response in the tumor microenvironment could effect cancer progression and prognosis. As components of systemic inflammatory response, lymphocytes, neutrophils, and platelets are being recognised to have an important role in carcinogenesis and tumor progression. To date, a number of peripheral blood-derived inflammation-based scores such as the neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR) and so on have been proposed as prognostic markers in numerous types of cancers. But, very little is known of their impact in subpopulation of lymphocytes. The investigators try to evaluate the activity of lymphocytes in peripheral blood and find out the relationship among clinical prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | lymphocyte | To evaluate the subpopulation of lymphocytes in cancer patients |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-06-01
- Completion
- 2018-12-01
- First posted
- 2015-08-05
- Last updated
- 2015-08-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02516371. Inclusion in this directory is not an endorsement.